Works matching IS 17424690 AND DT 2012 AND VI 9 AND IP Suppl 2

Results: 438

The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania.
Published in:
2012
By:
- Shao, E.;
- Nyombi, B.;
- Sabuni, J.
Publication type:
Abstract
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections.
Published in:
2012
By:
- Kwa, S.;
- Sadagopal, S.;
- Hong, J.;
- Gangadhara, S.;
- Basu, R.;
- Lai, L.;
- Iyer, S.;
- Araki, K.;
- Earl, P.L.;
- Wyatt, L.;
- Villinger, F.;
- Moss, B.;
- Ahmed, R.;
- Amara, R. R.
Publication type:
Abstract
E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost.
Published in:
2012
By:
- Hutnick, N. A.;
- Karuppiah, M.;
- Pollara, J.;
- Yan, J.;
- Myles, D. J.;
- Broderick, K.;
- Morrow, M.;
- Sardasai, N.;
- Montefiori, D.;
- Barnett, S.;
- Ferrari, G.;
- Weiner, D. B.
Publication type:
Abstract
HIV interactions and the perils of epithelial thinning in the female reproductive tract.
Published in:
2012
By:
- Carias, A.;
- McRaven, M.;
- Anderson, M.;
- Henning, T.;
- Kersh, E.;
- Smith, J.;
- Butler, K.;
- Vishwanathan, S.;
- McNicholl, J. M.;
- Hendry, R. M.;
- Veazey, R.;
- Hope, T.
Publication type:
Abstract
Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER.
Published in:
2012
By:
- Han, D.;
- Habte, H.;
- Qin, Y.;
- Takamoto, K.;
- LaBranche, C.;
- Montefiori, D.;
- Cho, M.W.
Publication type:
Abstract
Vector induced skewing of antibody Fc-effector functions.
Published in:
2012
By:
- Chung, A.;
- Dugast, A.;
- Robinson, H.;
- Chan, Y.;
- Ackerman, M.E.;
- Cox, J.;
- Koff, W.;
- Barouch, D.;
- Rerks-Ngarm, S.;
- Michael, N.;
- Kim, J.;
- Alter, G.
Publication type:
Abstract
Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge.
Published in:
2012
By:
- Shang, L.;
- Duan, J.;
- Smith, A.;
- Wietgrete, S.;
- Zupancic, M.;
- Haase, A.
Publication type:
Abstract
Virus-like particles highly expressing DC-SIGN concentrate trimeric HIV-envelope proteins with noncovalently linked immunoreactive gp120 and gp41.
Published in:
2012
By:
- Vyas, G. N.
Publication type:
Abstract
Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates.
Published in:
2012
By:
- Flamar, A.;
- Le Grand, R.;
- Contreras, V.;
- Zurawski, S.;
- Dereuddre-Bosquet, N.;
- Mangeot, I.;
- Martinon, F.;
- Oh, S.;
- Banchereau, J.;
- Zurawski, G.;
- Levy, Y.
Publication type:
Abstract
2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies.
Published in:
2012
By:
- Zhang, H.;
- Fu, H.;
- Liu, B.;
- Luallen, R. J.;
- Doms, R. W.;
- Smith, D. F.;
- Geng, Y.
Publication type:
Abstract
Simple, scalable and robust purification of two HIV-1 subtype C gp120 monomer subunit antigens for phase II clinical trial in Republic of South Africa.
Published in:
2012
By:
- Wen, Y.;
- Stephenson, S.;
- Zambonelli, C.;
- Hilt, S.;
- Wininger, M.;
- Dey, A.;
- Barnett, S.;
- Carfi, A.
Publication type:
Abstract
Novel AIDS vaccine approach using epithelial stem cells as mucosal antigen-presenting cells.
Published in:
2012
By:
- Bonello, G.;
- Chenciner, N.;
- White, R.;
- Salas, M.;
- Blancou, P.;
- Gauduin, M.
Publication type:
Abstract
Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans.
Published in:
2012
By:
- Katinger, D.;
- Wagner, A.;
- Luque, I.;
- Crespillo, S.;
- Conejero-Lara, F.;
- Roger, M.;
- Martin, C.;
- Mouz, N.;
- Mourao, S.;
- Farsang, A.;
- Notka, F.;
- Malcolm, K.;
- Bosquet, N.;
- Le Grand, R.;
- Moog, C.;
- Cope, A.;
- Shattock, R.;
- Lewis, D.J.;
- El Habib, R.
Publication type:
Abstract
Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies.
Published in:
2012
By:
- Evans, M. C.;
- Paquet, A.;
- Phung, P.;
- Parikh, A.;
- Petropoulos, C.;
- Wrin, T.;
- Haddad, M.
Publication type:
Abstract
Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine.
Published in:
2012
By:
- Saubi, N.;
- Gea-Mallorquí, E.;
- Mbewe-Mvula, A.;
- Hurtado, C.;
- Gatell, J.;
- Hanke, T.;
- Joseph, J.
Publication type:
Abstract
CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization.
Published in:
2012
By:
- Katinger, D.;
- Jeffs, S.;
- Altmann, F.;
- Cope, A.;
- McKay, P.;
- Almond, N.;
- Sandström, E.;
- Hejdeman, B.;
- Biberfeld, G.;
- Nilsson, C.;
- Hallengärd, D.;
- Wahren, B.;
- Lehner, T.;
- Singh, M.;
- Lewis, D.J.;
- Lacey, C.;
- Shattock, R.
Publication type:
Abstract
Design and development of a new lentiviral based anti-HIV therapeutic vaccine.
Published in:
2012
By:
- Rodriguez, M.;
- Sarry, E.;
- Bejanariu, A.;
- Casaban, L.;
- Abdalla, S.;
- Sabbah-Petrover, E.;
- Bauche, C.
Publication type:
Abstract
Determination of structural constraint within the HIV proteome through analysis of amino acid microenvironments.
Published in:
2012
By:
- Gaiha, G.;
- Anahtar, M.;
- Rossin, E.;
- Walker, B.
Publication type:
Abstract
DNA vaccines that express the MPER of HIV-1 gp41 elicit different antibodies depending upon their transmembrane and cytoplasmic domains.
Published in:
2012
By:
- Scott, J. K.;
- Gulzar, N.;
- Klaric, K.;
- Ross, T. M.;
- Lu, S.;
- Wang, S.
Publication type:
Abstract
Purification of chemically fixed HIV-1 spikes for oriented display on nanoparticles.
Published in:
2012
By:
- Zwick, M. B.;
- Leaman, D.
Publication type:
Abstract
Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization.
Published in:
2012
By:
- Acharya, P.;
- Luongo, T. S.;
- Matz, J.;
- Schmidt, S. D.;
- Chuang, G.;
- Georgiev, I.;
- Kessler, P.;
- Yang, Y.;
- Chames, P.;
- Martin, L.;
- Mascola, J. R.;
- Kwong, P. D.
Publication type:
Abstract
Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits.
Published in:
2012
By:
- Malherbe, D. C.;
- Hessell, A. J.;
- Sather, N. D.;
- Guo, B.;
- Pandey, S.;
- Pissani, F.;
- Robins, H.;
- Kalams, S.;
- Stamatatos, L.;
- Haigwood, N. L.
Publication type:
Abstract
Functional properties of an ensemble of candidate germline-encoded precursors of the anti-MPER antibody 4E10.
Published in:
2012
By:
- Finton, K.;
- Larmen, B.;
- Larimore, K.;
- Stuart, A.;
- Friend, D.;
- Vanden Bos, T.;
- Greenberg, P.;
- Elledge, S.;
- Stamatatos, L.;
- Strong, R.
Publication type:
Abstract
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime.
Published in:
2012
By:
- Wallace, A.;
- Duenas-Decamp, M. J.;
- Vaine, M.;
- Peters, P. J.;
- Wang, S.;
- Clapham, P. R.;
- Lu, S.
Publication type:
Abstract
Optimizing expression of functional HIV envelopes in rVSV-ΔG vaccine vectors.
Published in:
2012
By:
- Wright, K. J.;
- Yuan, M.;
- Wilson, A.;
- Boggiano, C.;
- Kemelman, M.;
- Tiberio, P.;
- Phogat, S.;
- Lorenz, I.;
- Hoffenberg, S.;
- Jurgens, C.;
- King, C.;
- Caulfield, M.;
- Parks, C.
Publication type:
Abstract
Viral vector delivery of Env trimer immunogens.
Published in:
2012
By:
- Parks, C. L.;
- Rabinovich, S.;
- Tiberio, P. J.;
- Wright, K. J.;
- Yuan, M.;
- Delboy, M. G.;
- Kemelman, M.;
- Wilson, A. J.;
- Powell, R. L.;
- Hoffenberg, S.;
- Chiuchiolo, M. J.;
- Boggiano, C.;
- Morrow, G.;
- Lorenz, I. C.;
- Jurgens, C. K.;
- Zhang, X.;
- Lindsay, R. W.;
- Koff, W. C.;
- King, C. R.;
- Caulfield, M. J.
Publication type:
Abstract
Co-immunization with HIV Env DNA and protein elicit long-lasting strong cellular and humoral immune responses.
Published in:
2012
By:
- Li, J.;
- Valentin, A.;
- Kulkarni, V.;
- Alicea, C.;
- Kelly Beach, R.;
- Rosati, M.;
- Jalah, R.;
- Reed, S.;
- Felber, B. K.;
- Pavlakis, G. N.
Publication type:
Abstract
Different biological activity of CD154-SIVgp41 fusion protein vaccine component in naïve or pre-immune individuals.
Published in:
2012
By:
- Smith, L. M.;
- Parodi, L. M.;
- Hodora, V. L.;
- Giavedoni, L. D.
Publication type:
Abstract
Skin tattooing as an effective tool for delivering DNA and protein vaccine immunogens.
Published in:
2012
By:
- Chiu, Y.;
- Jiang, X.;
- Kumar, R.;
- Hioe, C. E.;
- Zolla-Pazner, S.;
- Kong, X.
Publication type:
Abstract
Antigenic mimicry of mammalian oligomannose by a naturally occurring bacterial oligosaccharide and its implications for HIV vaccine design.
Published in:
2012
By:
- De Castro, C.;
- Clark, B. E.;
- Auyeung, K.;
- Marzaioli, A.;
- Stanfield, R. L.;
- Wilson, I. A.;
- Pantophlet, R.
Publication type:
Abstract
Oral delivery of transgenic plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to higher doses.
Published in:
2012
By:
- Lindh, I.;
- Bråve, A.;
- Hallengärd, D.;
- Haddad, R.;
- Strid, Å.;
- Andersson, S.
Publication type:
Abstract
A new strategy for repeated application of adenovirus based vectors: proof-of-concept in rhesus macaques challenged with SIVmac239.
Published in:
2012
By:
- Sun, C.;
- Feng, L.;
- Xiao, L.;
- Li, P.;
- Zhang, L.;
- Chen, L.
Publication type:
Abstract
Engineered microneedle arrays for transcutaneous HIV vaccine delivery.
Published in:
2012
By:
- DeMuth, P.;
- Huang, B.;
- Min, Y.;
- Barouch, D.;
- Hammond, P.;
- Irvine, D.
Publication type:
Abstract
Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines.
Published in:
2012
By:
- Yan, J.;
- Pankhong, P.;
- Khan, A. S.;
- Sardesai, N. Y.;
- Weiner, D. B.
Publication type:
Abstract
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies.
Published in:
2012
By:
- Shmelkov, E.;
- Krachmarov, C.;
- Grigoryan, A.;
- Agarwal, A.;
- Statnikov, A.;
- Cardozo, T.
Publication type:
Abstract
From HIV protein sequences to viral fitness landscapes: a new paradigm for in silico vaccine design.
Published in:
2012
By:
- Ferguson, A. L.;
- Chakraborty, A. K.
Publication type:
Abstract
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime.
Published in:
2012
By:
- Bauer, A.;
- Podola, L.;
- Haule, A.;
- Sudi, L.;
- Nilsson, C.;
- Mann, P.;
- Missanga, M.;
- Kaluwa, B.;
- Maboko, L.;
- Lueer, C.;
- Mwakatima, M.;
- Aboud, S.;
- Bakari, M.;
- Currier, J.;
- Robb, M.;
- Joseph, S.;
- McCormack, S.;
- Lyamuya, E.;
- Wahren, B.;
- Sandström, E.
Publication type:
Abstract
Evaluation of a replication-competent VSV-SIV vaccine candidate.
Published in:
2012
By:
- Jurgens, C. K.;
- Morrow, G.;
- Boggiano, C.;
- Panis, M.;
- Coleman, J.;
- Powell, R.;
- Yuan, M.;
- Kemelman, M.;
- Tamot, N.;
- Lopez, M.;
- Ouattara, A.;
- Iyer, S.;
- Backer, M.;
- Wright, K.;
- Domi, A.;
- Chiuchiolo, M.;
- King, C.R.;
- Caulfield, M.;
- Parks, C.
Publication type:
Abstract
Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients.
Published in:
2012
By:
- Levy, Y.;
- Thiébaut, R.;
- Montes, M.;
- Lacabaratz, C.;
- Sloan, L.;
- Perusat, S.;
- Harrod, C.;
- Boucherie, C.;
- Zurawski, S.;
- Richert, L.;
- Chêne, G.;
- Banchereau, J.;
- Palucka, K.
Publication type:
Abstract
Development of candidate HIV vaccines using VSV vectors to express membrane-anchored MPER immunogen.
Published in:
2012
By:
- Yuan, M.;
- Wilson, A.;
- Kemelman, M.;
- Panis, M.;
- Lorenz, I.;
- Jurgens, C.;
- Chiuchiolo, M. J.;
- King, R.;
- Caulfield, M.;
- Parks, C. L.
Publication type:
Abstract
Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens.
Published in:
2012
By:
- Grimm, S.;
- Ackerman, M.
Publication type:
Abstract
The C-terminal tail of HIV-1 envelope: a unique role for conserved LLP arginines in Env functional properties.
Published in:
2012
By:
- Kuhlmann, A.;
- Steckbeck, J. D.;
- Sturgeon, T. J.;
- Craigo, J. K.;
- Montelaro, R. C.
Publication type:
Abstract
The emptied bacteriophage T4 head: a novel nanoparticle vehicle to simultaneously deliver HIV-1 antigens and genes into dendritic cells.
Published in:
2012
By:
- Rao, V.
Publication type:
Abstract
Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development.
Published in:
2012
By:
- Polonis, V.;
- Wieczorek, L.;
- Kalyanaraman, V.;
- Matyas, G.;
- Whitney, S.;
- Williams, C.;
- Tovanabutra, S.;
- Sanders-Buell, E.;
- Wesberry, M.;
- Ochsenbauer, C.;
- Chenine, A.;
- Rao, M.;
- Tong, T.;
- Alving, C.;
- Cheng, H.;
- Zolla-Pazner, S.;
- Michael, N.;
- VanCott, T.;
- Marovich, M.
Publication type:
Abstract
Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design.
Published in:
2012
By:
- Wieczorek, L.;
- Rao, M.;
- Peachman, K.;
- Steers, N.;
- Marovich, M.;
- Michael, N.;
- Polonis, V.;
- Rao, V.
Publication type:
Abstract
Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors.
Published in:
2012
By:
- Mühle, M.;
- Bleiholder, A.;
- Hoffmann, K.;
- Löchelt, M.;
- Denner, J.
Publication type:
Abstract
Molecular epidemiology of the protective RV144 V2 loop epitope.
Published in:
2012
By:
- Cardozo, T.
Publication type:
Abstract
Development of an imaging based virus aggregation assay for vaccine development.
Published in:
2012
By:
- Stieh, D.;
- Gioia, C.;
- McRaven, M.;
- Cianci, G.;
- Kiser, P.;
- Hope, T.
Publication type:
Abstract
Transforming epitope-specific gp120 monomerbased probes into immunogens with N-linked glycan masking.
Published in:
2012
By:
- Chuang, G.;
- Boyington, J. C.;
- Nabel, G. J.;
- Kwong, P. D.;
- Georgiev, I.
Publication type:
Abstract
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition.
Published in:
2012
By:
- Weissenhorn, W.;
- Lutje Hulsik, D.;
- Hock, M.;
- Liu, Y. Y.;
- Strokappe, N. M.;
- Khattabi, M. E.;
- Langedijk, J. P.;
- McCoy, L. E.;
- Forsman-Quigley, A.;
- Aasa-Chapman, M. M.;
- Weiss, R. A.;
- Verrips, T. C.;
- Rutten, L.
Publication type:
Abstract